These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12773703)

  • 1. Subcutaneous adipose tissue pattern in lean and obese women with polycystic ovary syndrome.
    Tafeit E; Möller R; Rackl S; Giuliani A; Urdl W; Freytag U; Crailsheim K; Sudi K; Horejsi R
    Exp Biol Med (Maywood); 2003 Jun; 228(6):710-6. PubMed ID: 12773703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women.
    Horejsi R; Möller R; Rackl S; Giuliani A; Freytag U; Crailsheim K; Sudi K; Tafeit E
    Am J Phys Anthropol; 2004 Jul; 124(3):275-81. PubMed ID: 15197822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of risk profiles by subcutaneous adipose tissue topography in obese juveniles.
    Moeller R; Horejsi R; Pilz S; Lang N; Sargsyan K; Dimitrova R; Tafeit E; Giuliani A; Almer G; Mangge H
    Obesity (Silver Spring); 2007 May; 15(5):1319-24. PubMed ID: 17495209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences of subcutaneous adipose tissue topography in type-2 diabetic (NIDDM) women and healthy controls.
    Tafeit E; Möller R; Pieber TR; Sudi K; Reibnegger G
    Am J Phys Anthropol; 2000 Nov; 113(3):381-8. PubMed ID: 11042539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences of subcutaneous adipose tissue topography between type-2 diabetic men and healthy controls.
    Horejsi R; Möller R; Pieber TR; Wallner S; Sudi K; Reibnegger G; Tafeit E
    Exp Biol Med (Maywood); 2002 Oct; 227(9):794-8. PubMed ID: 12324659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthogonal factor coefficient development of subcutaneous adipose tissue topography (SAT-Top) in girls and boys.
    Tafeit E; Möller R; Sudi K; Horejsi R; Berg A; Reibnegger G
    Am J Phys Anthropol; 2001 May; 115(1):57-61. PubMed ID: 11309750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous fat patterns in type-2 diabetic men and healthy controls.
    Tafeit E; Horejsi R; Pieber TR; Roller RE; Schnedl WJ; Wallner SJ; Jurimae T; Möller R
    Coll Antropol; 2008 Jun; 32(2):607-14. PubMed ID: 18756918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Möller R; Horejsi R; Giuliani A; Kopera D; Schweighofer N; Groselj-Strele A; Pieber TR; Obermayer-Pietsch B
    Wien Klin Wochenschr; 2009; 121(7-8):262-9. PubMed ID: 19562283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.
    Vicennati V; Gambineri A; Calzoni F; Casimirri F; Macor C; Vettor R; Pasquali R
    Metabolism; 1998 Aug; 47(8):988-92. PubMed ID: 9711997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body fat distribution of overweight females with a history of weight cycling.
    Wallner SJ; Luschnigg N; Schnedl WJ; Lahousen T; Sudi K; Crailsheim K; Möller R; Tafeit E; Horejsi R
    Int J Obes Relat Metab Disord; 2004 Sep; 28(9):1143-8. PubMed ID: 15263924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.
    Faloia E; Canibus P; Gatti C; Frezza F; Santangelo M; Garrapa GG; Boscaro M
    J Endocrinol Invest; 2004 May; 27(5):424-9. PubMed ID: 15279073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous adipose tissue topography (SAT-Top) development in children and young adults.
    Tafeit E; Möller R; Jurimae T; Sudi K; Wallner SJ
    Coll Antropol; 2007 Jun; 31(2):395-402. PubMed ID: 17847915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determination of three subcutaneous adipose tissue compartments in non-insulin-dependent diabetes mellitus women with artificial neural networks and factor analysis.
    Tafeit E; Möller R; Sudi K; Reibnegger G
    Artif Intell Med; 1999 Oct; 17(2):181-93. PubMed ID: 10518050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of subcutaneous adipose tissue topography (SAT-Top) by means of a new optical device, LIPOMETER, and the evaluation of standard factor coefficients in healthy subjects.
    Möller R; Tafeit E; Pieber TR; Sudi K; Reibnegger G
    Am J Hum Biol; 2000 Mar; 12(2):231-239. PubMed ID: 11534020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROC and CART analysis of subcutaneous adipose tissue topography (SAT-Top) in type-2 diabetic women and healthy females.
    Tafeit E; Möller R; Sudi K; Reibnegger G
    Am J Hum Biol; 2000 May; 12(3):388-394. PubMed ID: 11534029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome.
    Kirchengast S; Huber J
    Hum Reprod; 2001 Jun; 16(6):1255-60. PubMed ID: 11387301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS).
    Martínez-García MÁ; Montes-Nieto R; Fernández-Durán E; Insenser M; Luque-Ramírez M; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E388-96. PubMed ID: 23337724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition.
    Sprung VS; Jones H; Pugh CJ; Aziz NF; Daousi C; Kemp GJ; Green DJ; Cable NT; Cuthbertson DJ
    Clin Sci (Lond); 2014 Jan; 126(1):67-74. PubMed ID: 23826984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.